| Patent No. | Patent Title: |
| 7122375 | PRO274 nucleic acids |
| 7112657 | PRO697 polypeptides |
| 7098003 | PRO 1384 nucleic acids |
| 7071171 | Unique dendritic cell-associated c-type lectins, dectin-1 and dec... |
| 7041646 | Methods of treating type 2 diabetes with peptides acting as both ... |
| 7041463 | Orthologues of human receptors and methods of use |
| 7026454 | Neuroendocrine marker of prostate cancer and method for producing... |
| 7009043 | Plus end-directed microtubule motor required for chromosome congr... |
| 6942978 | Transmembrane serine protease overexpressed in ovarian carcinoma ... |
| 6908619 | Camp factor of streptococcus uberis |
| 6872568 | Death domain containing receptor 5 antibodies |
| 6864066 | Epithelial protein lost in neoplasm (EPLIN) |
| 6828429 | Prostate-specific gene, PCGEM1, and the methods of using PCGEM1 t... |
| 6818746 | Secreted and transmembrane polypeptides and nucleic acids encodin... |
| 6818405 | Therapeutic use of the SMR1 protein and active derivatives thereo... |
| 6808930 | Therapeutic agents |
| 6797495 | Somatic cells with ablated PrP gene and methods of use |
| 6783986 | Sucrose phosphate synthetase (SPS), a preparation method and cDNA... |
| 6770450 | Treatment and diagnosis of cancer |
| 6770477 | Differentially expressed genes associated with HER-2/neu overexpr... |
| 6770457 | Process of purifying angiogenesis inhibitors |
| 6767711 | Treatment and diagnosis of prostate cancer |
| 6767541 | HER-2/neu overexpression abrogates growth inhibitory pathways |
| 6762283 | Caspase-8 interacting proteins |
| 6759204 | Method and kit for early diagnosis of cancer |
| 6759043 | Monoclonal antibodies having property of causing apoptosis |
| 6749853 | Combined methods and compositions for coagulation and tumor treat... |
| 6746865 | Nucleic acids encoding for endostatin protein |
| 6743898 | Monoclonal antibodies that suppress B cell growth and/or differen... |
| 6743602 | Polynucleotides differentially expressed in adenocarcinomas, poly... |
| 6740493 | Bone precursor cells: compositions and methods |
| 6740516 | Nucleic acid and amino acid sequences |
| 6740739 | Substitutional variants of APO-2 ligand |
| 6737259 | Modified arginine deiminase |
| 6737397 | Control of cancer growth through the interaction of [MET5]-enkeph... |
| 6734013 | Use of multivalent chimeric peptide-loaded, MHC/Ig molecules to d... |
| 6733752 | Prevention of tumors with monoclonal antibodies against neu |
| 6733992 | Isolated human Ras-like proteins, nucleic acid molecules encoding... |
| 6730296 | Chimeric polypeptides containing chemokine domains |
| 6727077 | Heregulin-like factor |
Bizarre Patents 
PatentStorm News
